Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder

PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be associated with dysregulated growth, including height and BMI. The reason for this association is yet unknown. The objective of this study w...

Full description

Saved in:
Bibliographic Details
Published in:Growth hormone & IGF research Vol. 65; p. 101485
Main Authors: Nemet, Dan, Ben-Zaken, Sigal, Eliakim, Roi A., Eliakim, Alon
Format: Journal Article
Language:English
Published: 01-08-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be associated with dysregulated growth, including height and BMI. The reason for this association is yet unknown. The objective of this study was to examine differences in growth hormone (GH) response to exercise between children who had received a diagnosis of ADHD and age- and gender-matched controls. We reasoned that the normal increase in circulating GH seen in response to exercise would be blunted in children with ADHD. METHODSWe recruited 13 treatment-naïve children with newly diagnosed ADHD and 14 age-matched controls (all male) and measured GH response to an exercise test in which the work was scaled to each subject's physical capability. RESULTSThere was no difference in the peak heart rate achieved during exercise between controls and ADHD participants (196.6 ± 1.5 vs. 196.5 ± 2.1 bpm, respectively) and lactate response to exercise (53.8 ± 5.0 vs. 47.9 ± 3.8 mg/dl, respectively). After exercise, GH increased significantly in the control subjects (p < 0.005), while GH responses were substantially blunted in the ADHD group (p = NS) even though the work performed did not differ from controls. CONCLUSIONSOur data suggest that GH excretion after exercise challenge in children with ADHD is impaired. This can be detected using a minimally invasive, nonpharmacologic challenge and may link ADHD with growth impairment in some children. TRIAL REGISTRATION NUMBERNCT00945971.
AbstractList PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be associated with dysregulated growth, including height and BMI. The reason for this association is yet unknown. The objective of this study was to examine differences in growth hormone (GH) response to exercise between children who had received a diagnosis of ADHD and age- and gender-matched controls. We reasoned that the normal increase in circulating GH seen in response to exercise would be blunted in children with ADHD. METHODSWe recruited 13 treatment-naïve children with newly diagnosed ADHD and 14 age-matched controls (all male) and measured GH response to an exercise test in which the work was scaled to each subject's physical capability. RESULTSThere was no difference in the peak heart rate achieved during exercise between controls and ADHD participants (196.6 ± 1.5 vs. 196.5 ± 2.1 bpm, respectively) and lactate response to exercise (53.8 ± 5.0 vs. 47.9 ± 3.8 mg/dl, respectively). After exercise, GH increased significantly in the control subjects (p < 0.005), while GH responses were substantially blunted in the ADHD group (p = NS) even though the work performed did not differ from controls. CONCLUSIONSOur data suggest that GH excretion after exercise challenge in children with ADHD is impaired. This can be detected using a minimally invasive, nonpharmacologic challenge and may link ADHD with growth impairment in some children. TRIAL REGISTRATION NUMBERNCT00945971.
ArticleNumber 101485
Author Nemet, Dan
Eliakim, Roi A.
Ben-Zaken, Sigal
Eliakim, Alon
Author_xml – sequence: 1
  givenname: Dan
  surname: Nemet
  fullname: Nemet, Dan
– sequence: 2
  givenname: Sigal
  surname: Ben-Zaken
  fullname: Ben-Zaken, Sigal
– sequence: 3
  givenname: Roi A.
  surname: Eliakim
  fullname: Eliakim, Roi A.
– sequence: 4
  givenname: Alon
  surname: Eliakim
  fullname: Eliakim, Alon
BookMark eNotkMtOwzAQRS1UJNrCD7Dykk2KH4njLFHFS0JCQrC2XHvSuErtYruU_j2Jwmpm7lzN1ZwFmvngAaFbSlaUUHG_W207F1eMMDYKpawu0JxWnBWMcTkbetKIQvC6vEKLlHaEkIbLco78B9ijAYvhF6JxCQrnJ2Ebwyl3uAtxP2ThBCZCdsFjPcxbbDrX2wgen9zg0jmDH7eFhdYZl3F3PkDUJrsfl8_YuhSihXiNLlvdJ7j5r0v09fT4uX4p3t6fX9cPb4VhkuRiQzQzFaGkbtsNNCWTVmrBGiZFO7xHq9pAyUohNpZTXZoGrK4pF4SIupYC-BLdTXcPMXwfIWW1d8lA32sP4ZgUE1JWjA8Bg5VNVhNDShFadYhur-NZUaJGuGqnRrhqhKsmuPwPMhdyaQ
CitedBy_id crossref_primary_10_1038_s41598_024_58009_7
crossref_primary_10_3389_fendo_2023_1163263
crossref_primary_10_1016_j_jaac_2023_03_015
crossref_primary_10_1038_s41390_023_02671_6
crossref_primary_10_1016_j_ghir_2024_101596
Cites_doi 10.1249/00005768-198205000-00012
10.1016/S0022-3476(77)80788-9
10.1542/peds.111.5.1010
10.1016/j.neubiorev.2020.09.031
10.1203/01.PDR.0000061750.71168.23
10.12659/MSM.890495
10.1016/S0002-7138(09)60719-6
10.1152/japplphysiol.01072.2005
10.1177/0009922820902437
10.1097/PSY.0000000000000787
10.1542/peds.2014-0428
10.4088/JCP.13l08580
10.1203/00006450-199311000-00016
10.1097/00004583-199611000-00014
10.1111/jcpp.12684
10.1097/01.chi.0000235075.25038.5a
10.1016/0024-3205(84)90415-6
10.1123/pes.20.4.370
10.1016/0024-3205(87)90060-9
10.1542/peds.70.6.987
10.1046/j.1365-2265.2003.01847.x
10.1016/j.jpeds.2015.08.036
10.1530/eje.1.02186
10.3390/genes12091407
10.1210/clinem/dgab846
10.1097/00004583-199603000-00006
10.1016/j.neubiorev.2021.01.022
ContentType Journal Article
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.ghir.2022.101485
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1532-2238
EndPage 101485
ExternalDocumentID 10_1016_j_ghir_2022_101485
GroupedDBID ---
--K
--M
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AACTN
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXKI
AAXUO
AAYXX
ABBQC
ABGSF
ABJNI
ABMAC
ABMZM
ABUDA
ABXDB
ACDAQ
ACGFS
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AEVXI
AFCTW
AFJKZ
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJOXV
AJRQY
AJUYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
CAG
CITATION
COF
CS3
DU5
EBS
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OB0
ON-
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SDP
SEL
SES
SEW
SPCBC
SSH
SSU
SSZ
T5K
Z5R
~G-
7X8
ID FETCH-LOGICAL-c280t-b0a2c50107ffbe9428d8a629286f101157ce42466bd31a4c9eda71360067786e3
ISSN 1096-6374
IngestDate Sat Oct 05 06:25:18 EDT 2024
Thu Sep 26 15:41:56 EDT 2024
IsPeerReviewed true
IsScholarly true
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c280t-b0a2c50107ffbe9428d8a629286f101157ce42466bd31a4c9eda71360067786e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PQID 2688523107
PQPubID 23479
PageCount 1
ParticipantIDs proquest_miscellaneous_2688523107
crossref_primary_10_1016_j_ghir_2022_101485
PublicationCentury 2000
PublicationDate 2022-08-00
20220801
PublicationDateYYYYMMDD 2022-08-01
PublicationDate_xml – month: 08
  year: 2022
  text: 2022-08-00
PublicationDecade 2020
PublicationTitle Growth hormone & IGF research
PublicationYear 2022
References De Zegher (10.1016/j.ghir.2022.101485_bb0070) 1993; 34
Pliszka (10.1016/j.ghir.2022.101485_bb0010) 1996; 35
Eliakim (10.1016/j.ghir.2022.101485_bb0110) 2008; 20
Borg (10.1016/j.ghir.2022.101485_bb0120) 1982; 14
Davallow Ghajar (10.1016/j.ghir.2022.101485_bb0015) 2020; 59
Swanson (10.1016/j.ghir.2022.101485_bb0030) 2017; 58
Kim (10.1016/j.ghir.2022.101485_bb0080) 2020; 31
Wigal (10.1016/j.ghir.2022.101485_bb0115) 2003; 53
Wittert (10.1016/j.ghir.2022.101485_bb0105) 2000
Loewen (10.1016/j.ghir.2022.101485_bb0145) 2020; 82
Eliakim (10.1016/j.ghir.2022.101485_bb0135) 2006; 100
Dmitrzak-Weglarz (10.1016/j.ghir.2022.101485_bb0140) 2021; 12
Biederman (10.1016/j.ghir.2022.101485_bb0025) 2003; 111
Trainer (10.1016/j.ghir.2022.101485_bb0125) 2006; 155
Hunt (10.1016/j.ghir.2022.101485_bb0090) 1984; 35
Rose (10.1016/j.ghir.2022.101485_bb0060) 2015; 167
Giordano (10.1016/j.ghir.2022.101485_bb0130) 2003; 59
Aarskog (10.1016/j.ghir.2022.101485_bb0085) 1977; 90
Schultz (10.1016/j.ghir.2022.101485_bb0095) 1982; 70
Harstad (10.1016/j.ghir.2022.101485_bb0035) 2014; 134
Greenhill (10.1016/j.ghir.2022.101485_bb0100) 1981; 20
Swanson (10.1016/j.ghir.2022.101485_bb0055) 2006; 45
Peyre (10.1016/j.ghir.2022.101485_bb0040) 2013; 74
Carucci (10.1016/j.ghir.2022.101485_bb0050) 2021; 120
Weizman (10.1016/j.ghir.2022.101485_bb0075) 1987; 40
Spencer (10.1016/j.ghir.2022.101485_bb0020) 1996; 35
Faraone (10.1016/j.ghir.2022.101485_bb0005) 2021; 128
Pinhas-Hamiel (10.1016/j.ghir.2022.101485_bb0045) 2022; 107
Ptacek (10.1016/j.ghir.2022.101485_bb0065) 2014; 20
References_xml – volume: 14
  start-page: 377
  year: 1982
  ident: 10.1016/j.ghir.2022.101485_bb0120
  article-title: Psychophysical bases of perceived exertion
  publication-title: Med. Sci. Sports Exerc.
  doi: 10.1249/00005768-198205000-00012
  contributor:
    fullname: Borg
– volume: 90
  start-page: 136
  year: 1977
  ident: 10.1016/j.ghir.2022.101485_bb0085
  article-title: The effect of the stimulant drugs, dextroamphetamine and methylphenidate, on secretion of growth hormone in hyperactive children
  publication-title: J. Pediatr.
  doi: 10.1016/S0022-3476(77)80788-9
  contributor:
    fullname: Aarskog
– volume: 111
  start-page: 1010
  year: 2003
  ident: 10.1016/j.ghir.2022.101485_bb0025
  article-title: Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development, and treatment
  publication-title: Pediatrics
  doi: 10.1542/peds.111.5.1010
  contributor:
    fullname: Biederman
– volume: 120
  start-page: 509
  year: 2021
  ident: 10.1016/j.ghir.2022.101485_bb0050
  article-title: Long term methylphenidate exposure and growth in children and adolescents with ADHD. A systematic review and meta-analysis
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2020.09.031
  contributor:
    fullname: Carucci
– volume: 53
  start-page: 756
  year: 2003
  ident: 10.1016/j.ghir.2022.101485_bb0115
  article-title: Catecholamine response to exercise in children with attention deficit hyperactivity disorder
  publication-title: Pediatr. Res.
  doi: 10.1203/01.PDR.0000061750.71168.23
  contributor:
    fullname: Wigal
– volume: 20
  start-page: 608
  year: 2014
  ident: 10.1016/j.ghir.2022.101485_bb0065
  article-title: Disruptive patterns of eating behaviors and associated lifestyles in males with ADHD
  publication-title: Med. Sci. Monit.
  doi: 10.12659/MSM.890495
  contributor:
    fullname: Ptacek
– volume: 20
  start-page: 84
  year: 1981
  ident: 10.1016/j.ghir.2022.101485_bb0100
  article-title: Growth hormone, prolactin, and growth responses in hyperkinetic males treated with d-amphetamine
  publication-title: J Am Acad Child Psychiatry
  doi: 10.1016/S0002-7138(09)60719-6
  contributor:
    fullname: Greenhill
– volume: 100
  start-page: 1630
  year: 2006
  ident: 10.1016/j.ghir.2022.101485_bb0135
  article-title: Reduced exercise-associated response of the GH-IGF-I axis and catecholamines in obese children and adolescents
  publication-title: J. Appl. Physiol.
  doi: 10.1152/japplphysiol.01072.2005
  contributor:
    fullname: Eliakim
– start-page: 43
  year: 2000
  ident: 10.1016/j.ghir.2022.101485_bb0105
  contributor:
    fullname: Wittert
– volume: 59
  start-page: 401
  year: 2020
  ident: 10.1016/j.ghir.2022.101485_bb0015
  article-title: Children with attention-deficit/hyperactivity disorder are at increased risk for slowed growth and short stature in early childhood
  publication-title: Clin. Pediatr.
  doi: 10.1177/0009922820902437
  contributor:
    fullname: Davallow Ghajar
– volume: 82
  start-page: 305
  year: 2020
  ident: 10.1016/j.ghir.2022.101485_bb0145
  article-title: Adherence to life-style recommendations and attention-deficit/hyperactivity disorder: a population-based study of children aged 10 to 11 years
  publication-title: Psychosom. Med.
  doi: 10.1097/PSY.0000000000000787
  contributor:
    fullname: Loewen
– volume: 134
  start-page: e935
  year: 2014
  ident: 10.1016/j.ghir.2022.101485_bb0035
  article-title: ADHD, stimulant treatment, and growth: a longitudinal study
  publication-title: Pediatrics
  doi: 10.1542/peds.2014-0428
  contributor:
    fullname: Harstad
– volume: 74
  start-page: 1123
  year: 2013
  ident: 10.1016/j.ghir.2022.101485_bb0040
  article-title: Long-term effects of ADHD medication on adult height: results from the NESARC
  publication-title: J Clin Psychiatry
  doi: 10.4088/JCP.13l08580
  contributor:
    fullname: Peyre
– volume: 34
  start-page: 642
  year: 1993
  ident: 10.1016/j.ghir.2022.101485_bb0070
  article-title: Dopamine inhibits growth hormone and prolactin secretion in the human newborn
  publication-title: Pediatr. Res.
  doi: 10.1203/00006450-199311000-00016
  contributor:
    fullname: De Zegher
– volume: 35
  start-page: 1460
  year: 1996
  ident: 10.1016/j.ghir.2022.101485_bb0020
  article-title: Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
  doi: 10.1097/00004583-199611000-00014
  contributor:
    fullname: Spencer
– volume: 58
  start-page: 663
  year: 2017
  ident: 10.1016/j.ghir.2022.101485_bb0030
  article-title: Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression
  publication-title: J. Child Psychol. Psychiatry
  doi: 10.1111/jcpp.12684
  contributor:
    fullname: Swanson
– volume: 45
  start-page: 1304
  year: 2006
  ident: 10.1016/j.ghir.2022.101485_bb0055
  article-title: Stimulant-related reductions of growth rates in the PATS
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
  doi: 10.1097/01.chi.0000235075.25038.5a
  contributor:
    fullname: Swanson
– volume: 35
  start-page: 885
  year: 1984
  ident: 10.1016/j.ghir.2022.101485_bb0090
  article-title: Possible change in noradrenergic receptor sensitivity following methylphenidate treatment: growth hormone and MHPG response to clonidine challenge in children with attention deficit disorder and hyperactivity
  publication-title: Life Sci.
  doi: 10.1016/0024-3205(84)90415-6
  contributor:
    fullname: Hunt
– volume: 20
  start-page: 370
  year: 2008
  ident: 10.1016/j.ghir.2022.101485_bb0110
  article-title: Exercise provocation test for growth hormone secretion: methodologic considerations
  publication-title: Pediatr. Exerc. Sci.
  doi: 10.1123/pes.20.4.370
  contributor:
    fullname: Eliakim
– volume: 40
  start-page: 2247
  year: 1987
  ident: 10.1016/j.ghir.2022.101485_bb0075
  article-title: Effects of acute and chronic methylphenidate administration on beta-endorphin, growth hormone, prolactin and cortisol in children with attention deficit disorder and hyperactivity
  publication-title: Life Sci.
  doi: 10.1016/0024-3205(87)90060-9
  contributor:
    fullname: Weizman
– volume: 70
  start-page: 987
  year: 1982
  ident: 10.1016/j.ghir.2022.101485_bb0095
  article-title: Methylphenidate treatment of hyperactive children: effects on the hypothalamic-pituitary-somatomedin axis
  publication-title: Pediatrics
  doi: 10.1542/peds.70.6.987
  contributor:
    fullname: Schultz
– volume: 59
  start-page: 314
  year: 2003
  ident: 10.1016/j.ghir.2022.101485_bb0130
  article-title: Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans
  publication-title: Clin. Endocrinol.
  doi: 10.1046/j.1365-2265.2003.01847.x
  contributor:
    fullname: Giordano
– volume: 167
  start-page: 1389
  year: 2015
  ident: 10.1016/j.ghir.2022.101485_bb0060
  article-title: Attention-deficit/hyperactivity disorder medication treatment impact on response to growth hormone therapy: results from the ANSWER program, a non-interventional study
  publication-title: J. Pediatr.
  doi: 10.1016/j.jpeds.2015.08.036
  contributor:
    fullname: Rose
– volume: 155
  start-page: 1
  year: 2006
  ident: 10.1016/j.ghir.2022.101485_bb0125
  article-title: Consensus statement on the standardisation of GH assays
  publication-title: Eur. J. Endocrinol.
  doi: 10.1530/eje.1.02186
  contributor:
    fullname: Trainer
– volume: 12
  year: 2021
  ident: 10.1016/j.ghir.2022.101485_bb0140
  article-title: Common and unique genetic background between attention-deficit/hyperactivity disorder and excessive body weight
  publication-title: Genes (Basel)
  doi: 10.3390/genes12091407
  contributor:
    fullname: Dmitrzak-Weglarz
– volume: 31
  start-page: 154
  year: 2020
  ident: 10.1016/j.ghir.2022.101485_bb0080
  article-title: Preliminary investigation of association between methylphenidate and serum growth markers in children with attention-deficit/hyperactivity disorder: a cross-sectional case-control study
  publication-title: Soa Chongsonyon Chongsin Uihak
  contributor:
    fullname: Kim
– volume: 107
  start-page: e1434
  year: 2022
  ident: 10.1016/j.ghir.2022.101485_bb0045
  article-title: Attention-deficit/hyperactivity disorder and obesity: a National Study of 1.1 million Israeli adolescents
  publication-title: J. Clin. Endocrinol. Metab.
  doi: 10.1210/clinem/dgab846
  contributor:
    fullname: Pinhas-Hamiel
– volume: 35
  start-page: 264
  year: 1996
  ident: 10.1016/j.ghir.2022.101485_bb0010
  article-title: Catecholamines in attention-deficit hyperactivity disorder: current perspectives
  publication-title: J. Am. Acad. Child Adolesc. Psychiatry
  doi: 10.1097/00004583-199603000-00006
  contributor:
    fullname: Pliszka
– volume: 128
  start-page: 789
  year: 2021
  ident: 10.1016/j.ghir.2022.101485_bb0005
  article-title: The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder
  publication-title: Neurosci. Biobehav. Rev.
  doi: 10.1016/j.neubiorev.2021.01.022
  contributor:
    fullname: Faraone
SSID ssj0009384
Score 2.3845825
Snippet PURPOSEAttention-deficit/hyperactivity disorder (ADHD) is typically a chronic, often lifelong condition. Data suggest that ADHD itself and its treatment may be...
SourceID proquest
crossref
SourceType Aggregation Database
StartPage 101485
Title Reduced exercise-induced growth hormone secretion among children with attention-deficit hyperactivity disorder
URI https://search.proquest.com/docview/2688523107
Volume 65
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9tAEF4cB0ovpU1amrYJWwi9iA3SSlqtj24j50GaQuOA6UWstSvbecillg-F_vjOPmRJySU99CLMIMli5mN2ZnfmG4QOA8n9XLKYDHhQkEgyn2hWKwJLvxC-Xwga6Obk06vkcsKP0yjt9f7UWf9G9l8tDTKwte6c_Qdrb14KAvgNNocrWB2uT7L7d83FClFkPUuJQNJtBDNIuKu5N4cgdQmR5UrHi3ZMuJk31Onq9jTrpqmDJFJpjonKm0PCajqqzLAJ6Ug727HtSfcPNKbOTkaeoxNqbTvf2wOQ4waYn1VJfohb6wKvFjOxqftI7xYQ49pZzMtFs_Pakg_vHLTc5gXkvXXpHKw9tcOlBEIU3vbILG65VD1M2E71cQt0I3jk_u1OxM3RbL7QXK-UHrWfbnNtX37LRtcXF9k4nYy30DYFNxX30fbwLJ2cN6TNIY9co5WtCXz43m4w013LTYAyfoleuMwCDy0kXqGeKnfQ7rAU1fL-N_6ETa2vOUTZQc--upKKXVQ6wOCHgMEWMNjZE28Agw1gcA0YrAGDHwEGdwCDa8C8RtejdPzllLghHCSn3K_I1Bc0jyFrT4piqgaQrUouGB1QzopA5xNJriIaMTaVYSCifKCkSIKQ-ZaaUIVvUL-Er3yLsPBFLmVeFLq7MleCywgeiqiE26Jwmu8hr9Zm9tNyrWR1EeJNpnWfad1nVvd76GOt8Axcoj7nEqVarlcZZZzHOm9J3j3hnvfoeYPMD6hf_VqrfbS1kusDh4e_pK2GSw
link.rule.ids 315,782,786,27935,27936
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Reduced+exercise-induced+growth+hormone+secretion+among+children+with+attention-deficit+hyperactivity+disorder&rft.jtitle=Growth+hormone+%26+IGF+research&rft.au=Nemet%2C+Dan&rft.au=Ben-Zaken%2C+Sigal&rft.au=Eliakim%2C+Roi+A&rft.au=Eliakim%2C+Alon&rft.date=2022-08-01&rft.eissn=1532-2238&rft.volume=65&rft.spage=101485&rft.epage=101485&rft_id=info:doi/10.1016%2Fj.ghir.2022.101485&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6374&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6374&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6374&client=summon